B Baron

Author PubWeight™ 57.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst 2000 5.62
2 Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 2000 4.25
3 Most classical Mus musculus domesticus laboratory mouse strains carry a Mus musculus musculus Y chromosome. Nature 1985 3.94
4 Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol 2002 3.91
5 Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998 3.22
6 New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993 2.10
7 Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol 2003 2.01
8 Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952. J Clin Oncol 2003 1.82
9 Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer 2003 1.70
10 A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. Eur J Cancer 2005 1.58
11 [Cardiotoxicity of fluorouracil: a real but unexplained phenomenon]. Presse Med 1991 1.38
12 Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. Ann Oncol 2003 1.08
13 Maximal lactate steady state, respiratory compensation threshold and critical power. Eur J Appl Physiol 2003 1.04
14 Abdomino-transsacral resection and anastomosis for mid-rectal cancer. Ann Surg 1973 1.04
15 Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group. Ann Oncol 2004 1.01
16 oriGNAI3: a narrow zone of preferential replication initiation in mammalian cells identified by 2D gel and competitive PCR replicon mapping techniques. Nucleic Acids Res 1998 1.01
17 Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann Oncol 2005 1.00
18 Flow cytometry isolation and improved visualization of sorted mouse chromosomes. Purification of chromosomes X and ISO-1 from cell lines with Robertsonian translocations. Exp Cell Res 1984 0.97
19 Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999 0.95
20 Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 2002 0.94
21 Alternative splicing prevents transferrin secretion during differentiation of a human oligodendrocyte cell line. J Neurosci Res 2000 0.91
22 Phase II study of E7070 in patients with metastatic melanoma. Ann Oncol 2005 0.90
23 European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme. Ann Oncol 2003 0.89
24 Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 2001 0.86
25 Hemodynamic effects of arteriovenous fistulae in chronic hemodialysis patients at rest and during exercise. Clin Nephrol 1981 0.83
26 Transgenic mice as a model to study the regulation of human transferrin expression in Sertoli cells. Hum Reprod 2004 0.83
27 [Myocardial infarction with normal coronary angiography. Apropos of 9 cases. A retrospective and comparative study]. Ann Cardiol Angeiol (Paris) 1996 0.83
28 Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group. Eur J Cancer 2004 0.82
29 Cloning of DNA libraries from mouse Y chromosomes purified by flow cytometry. Somat Cell Mol Genet 1986 0.81
30 The influence of variable resistance moment arm on knee extensor performance. J Sports Sci 2010 0.81
31 Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study. Eur J Cancer 2004 0.80
32 Matrix attachment regions and transcription units in a polygenic mammalian locus overlapping two isochores. J Cell Biochem 1997 0.79
33 Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group. Eur J Cancer 2004 0.78
34 Changes in the expression of cytoskeletal proteins in the CNS of transferrin transgenic mice. Dev Neurosci 2002 0.78
35 Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with alpha-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial. Eur J Cancer 2002 0.78
36 Plasma catecholamine and haemodynamic responses to surgical endodontic anaesthetic protocols. Int Endod J 1996 0.77
37 Statistical methodology of phase III cancer clinical trials: advances and future perspectives. Eur J Cancer 2002 0.77
38 Molecular characterization of an 18 kb segment of DNA puff C4 of Bradysia hygida (Diptera, sciaridae). Chromosoma 1995 0.77
39 Twelve genes, including the unassigned proteasome zeta subunit gene, ordered within the human 1p13 region. Mamm Genome 1998 0.76
40 Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report. J Urol 1978 0.76
41 The use of Daphnia magna for detection of okadaic acid in mussel extracts. Food Addit Contam 1993 0.76
42 Transducing properties of a pre-structured α-helical DPT-peptide containing a short canine adenovirus type 2 E4orf4 PP2A1-binding sequence. Biochim Biophys Acta 2013 0.76
43 Cholinergic urticaria, copper-induced hypersensitivity, and muscarinic receptors. Lancet 1983 0.75
44 Indicators of clinically significant red cell antibodies produced by sensitized lymphocytes in liver transplant patients. Immunohematology 1991 0.75
45 Copper ions and diamide induce a high affinity guanine-nucleotide-insensitive state for muscarinic agonists. Biochem Biophys Res Commun 1984 0.75
46 Could inspiratory apnea disturb left ventricular volume assessment by contrast angiography? Cardiovasc Intervent Radiol 1987 0.75
47 Hemodynamic effects of intravenous diltiazem in patients treated chronically with propranolol. Am Heart J 1986 0.75
48 [Capacity of muscular effort and oxygen transport in chronic hemodialysis patients]. J Urol Nephrol (Paris) 1979 0.75
49 Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties. Arch Biochem Biophys 1985 0.75
50 Arteriovenous shunt measured by bolus dye dilution: reproducibility and comparison between two injection sites. Cathet Cardiovasc Diagn 1985 0.75
51 [Influence of preload changes on the filling function of the left heart ventricle studied by Doppler echocardiography]. Arch Mal Coeur Vaiss 1990 0.75
52 [Left ventricular performance in chronic hemodialysis patients studied during intense exercise and during a dextran infusion test (author's transl)]. Nephrologie 1981 0.75
53 [Defibrillation in aircraft : what is the danger?]. Presse Med 1990 0.75
54 Contra Costa County takes care of its own. Interview by Terese Hudson. Hosp Health Netw 1996 0.75
55 RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group. Eur J Cancer 2004 0.75
56 Arteriovenous fistula (AVF) blood flow in chronic haemodialysis patients (CHP): comparison of results obtained by the dye-dilution method (OAVF) and by variations in cardiac output during temporary occlusion of the AVF (delta QC). Proc Eur Dial Transplant Assoc 1979 0.75
57 [Use of amiodarone in pregnant women]. Presse Med 1988 0.75
58 Solubilization and characterization of muscarinic receptors from bovine brain. Life Sci 1984 0.75
59 The development of a role charter for nursing unit administrators. Can J Nurs Adm 1988 0.75
60 Acute hemodynamic effects of intravenous nicardipine in patients treated chronically with propranolol for coronary artery disease. Am J Cardiol 1987 0.75
61 Atlantooccipital dislocation: MR demonstration of cord damage. J Comput Assist Tomogr 1991 0.75
62 Aortic percutaneous transluminal valvuloplasty in elderly patients by balloon larger than aortic anulus. Cathet Cardiovasc Diagn 1988 0.75
63 Elution mode of Pneumocystis carinii cysts in gravitational field-flow fractionation. J Chromatogr 1992 0.75
64 Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol. Cardiovasc Drugs Ther 1997 0.75
65 Fatty acid incorporation increases the affinity of muscarinic cholinergic receptors for agonists. Biochim Biophys Acta 1984 0.75
66 Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors. Invest New Drugs 2004 0.75
67 [Bepridil and bundle of His block. Apropos of a case]. Arch Mal Coeur Vaiss 1988 0.75
68 Bimonthly cranial MRI activity following an isolated monosymptomatic demyelinating syndrome: potential outcome measures for future multiple sclerosis 'prevention' trials. Mult Scler 1999 0.75
69 High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group. Eur J Cancer 2003 0.75
70 [P wave changes and atrial fibrillation after implantation of VVI type pacemaker]. Arch Mal Coeur Vaiss 1992 0.75
71 Differences between somatic growth curves of males and females are a secondary sex characteristic. Med Hypotheses 1984 0.75
72 Linearization of human growth curves affords new classification of dwarfism. Med Hypotheses 1985 0.75